Search Results for: clinicaltrials.gov

Regenerative reads: brain organoids, Clinicaltrials.gov change

/ / 1 Comment
brain organoids sm

Sometimes change takes a very long time, but with brain organoids or advocating for better information for patients at Clinicaltrials.gov, after waiting you can see some interesting developments.  These are two of the regenerative medicine stories of the week, along with some striking research papers. Clinicaltrials.gov Some of us have been advocating for improvements at […]

Regenerative reads: brain organoids, Clinicaltrials.gov change Read More »

FDA outlines potential crackdown on Clinicaltrials.gov offenders

/ / 11 Comments
Anderson-et-al-Clinicaltrials.gov_

Clinicaltrials.gov is a wonderful resource for its many users, whether a patient searching for a clinical trial to actually participate in or someone doing research as I have done, but it’s not perfect and some sponsors have been breaking the rules regarding its use. It’s a major problem in fact. Based on new draft guidance

FDA outlines potential crackdown on Clinicaltrials.gov offenders Read More »

Clinicaltrials.gov Mission At Risk From Proliferating For-Profit Trials

/ / 3 Comments
slickstem

It’s hard to even imagine the world of investigative medicine without the wonderful resource of Clinicaltrials.gov, the global hub for clinical trial listings. I recently interviewed the Director of Clinicaltrials.gov, Dr. Deborah Zarin here, which is a fascinating read. As great as Clinicaltrials.gov is as a resource, unfortunately it faces a new, rapidly growing problem that is a serious

Clinicaltrials.gov Mission At Risk From Proliferating For-Profit Trials Read More »

Interview with Clinicaltrials.gov Director Deborah Zarin

/ / 4 Comments
clinicaltrials.gov_

This post is the first in a series about the Clinicaltrials.gov website. This piece is an interview the Director, Dr. Deborah Zarin. I want to thank her for taking the time to answer my questions. Later, I will post Part 2 in which I discuss my concerns about the trend of for-profit stem cell clinic trials

Interview with Clinicaltrials.gov Director Deborah Zarin Read More »

Recommended reads: private cord blood bank disappointments, Mammoth genomes, Huntington’s CRISPR, Parkinson’s cell therapy

/ / Leave a Comment
umbilical-cord-blood, umbilical cord blood stem cells

The private cord blood bank industry has promised families all kinds of great things over the years. A typical ad for such cord blood banks might say, “Your child may need cord blood in the future for a cure.” The industry also often uses the analogy of frozen cord blood as an insurance policy for

Recommended reads: private cord blood bank disappointments, Mammoth genomes, Huntington’s CRISPR, Parkinson’s cell therapy Read More »

Concerns after interview with Kyle Cetrulo of Perinatal Stem Cell Society

/ / Leave a Comment
Perinatal Stem Cell Society email material.

I recently interviewed Kyle Cetrulo of the Perinatal Stem Cell Society. This organization seeks to catalyze big changes in stem cell use and clinical trials in the U.S. In the interview, we touched on many topics including FDA oversight of the cell therapy space. Some of this discussion was in reaction to the new Utah

Concerns after interview with Kyle Cetrulo of Perinatal Stem Cell Society Read More »

Is Liz Parrish the world’s most genetically modified person? Why it might not be such a good thing

/ / 10 Comments
Liz Parrish, BioViva

Some recent claims had me wondering whether Liz Parrish is the world’s most genetically modified person. She and her firm BioViva are making that claim. It’s an important question but maybe not for the reason many of us first might think. This is not really about one person. Instead, this is a weighty question because

Is Liz Parrish the world’s most genetically modified person? Why it might not be such a good thing Read More »

US clinics selling unproven RGCC cell therapies in addition to SOT

/ / 5 Comments
FL RGCC cell therapy

I wrote a few weeks ago about a firm called RGCC or Research Genetic Cancer Center, which sells what I see as an unproven RNA therapy to clinics throughout the US. The approach is called supportive oligonucleotide therapy or SOT. After buying it from RGCC, the clinics then sell SOT injections for Lyme disease, other

US clinics selling unproven RGCC cell therapies in addition to SOT Read More »

Perspectives on new stem cells for paralysis paper & media coverage

/ / 5 Comments
stem cells for paralysis

A new paper on stem cells for paralysis from a Mayo Clinic team has sparked a bit of legitimate hope but also some hype in the media. The publication was in Nature Communications. It is entitled “Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial.” The approach was direct injection

Perspectives on new stem cells for paralysis paper & media coverage Read More »

US clinics widely selling unproven RNA therapy, supportive oligonucleotide therapy or SOT, from Greek firm RGCC

/ / 8 Comments
SOT, supportive oligonucleotide therapy

A few dozen clinics in the US sell an unproven RNA therapy called supportive oligonucleotide therapy or SOT. The product comes from a Greek firm RGCC or Research Genetic Cancer Center, which also pre-tests patients’ gene expression to design the RNA product. Clinics marketing SOT in the US say it is intended to act by

US clinics widely selling unproven RNA therapy, supportive oligonucleotide therapy or SOT, from Greek firm RGCC Read More »